Prot# XP055: An Open-Label, 52-Week Extension Study Assessing XP13512 Safety and Efficacy in Patients with Restless Legs Syndrome

Project: Research project

Project Details

StatusFinished
Effective start/end date7/14/06 → 11/22/11

Funding

  • XenoPort, Inc. (XP055)